✦ LIBER ✦

Erlotinib (Tarceva): An update on the clinical trial program

✍ Scribed by Roy S. Herbst

Book ID: 114106752
Publisher: Elsevier Science
Year: 2003
Tongue: English
Weight: 252 KB
Volume: 30
Category: Article
ISSN: 0093-7754
DOI: 10.1016/s0093-7754(03)70013-x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Lenalidomide: an update on evidence from

Lenalidomide: an update on evidence from clinical trials

✍ Meletios-Athanassios Dimopoulos; Evangelos Terpos 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 110 KB

Lenalidomide is a novel immunomodulatory agent with a unique dual mechanism of action: its tumoricidal effect leads to direct tumor cell death, and its immunomodulatory effect keeps the tumor in remission. Phase III clinical trials have demonstrated that in patients with relapsed/ refractory multipl

Clinical trials including an update on t

Clinical trials including an update on the Helsinki heart study

✍ W.Virgil Brown 📂 Article 📅 1990 🏛 Elsevier Science 🌐 English ⚖ 579 KB

The ketogenic diet—update on recent clin

The ketogenic diet—update on recent clinical trials

✍ J. Helen Cross; Elizabeth G. Neal 📂 Article 📅 2008 🏛 Wiley (Blackwell Publishing) 🌐 English ⚖ 85 KB

Safety of oral ciprofloxacin: An update

Safety of oral ciprofloxacin: An update based on clinical trial results

✍ Peter Schacht; George Arcieri; Rainer Hullmann 📂 Article 📅 1989 🏛 Elsevier Science 🌐 English ⚖ 550 KB

Protection against stroke and dementia:

Protection against stroke and dementia: An update on the latest clinical trial evidence

✍ Bryan Williams 📂 Article 📅 2004 🏛 Springer 🌐 English ⚖ 883 KB

Ezetimibe: an update on the mechanism of

Ezetimibe: an update on the mechanism of action, pharmacokinetics and recent clinical trials

✍ Sweeney, Mary Ellen; Johnson, Rebecca R 📂 Article 📅 2007 🏛 Informa plc 🌐 English ⚖ 167 KB